http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2186023-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 |
| filingDate | 1995-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06cfa9a9cf85dfb30a8881b6f8ec88d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53eedee8068ceddaefe2bb52a0327d85 |
| publicationDate | 1995-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2186023-A1 |
| titleOfInvention | Process for preparing 2-piperazine carboxylic acid derivatives |
| abstract | The invention concerns a process for preparing 2-piperazine carboxylic acid amides of general formula (I): (I) wherein a piperazine carboxylic acid, N-acylated with a halogenating agent to form a piperazine carboxylic acid anhydride of general formula (IV): (IV) is cyclized and finally converted into the end product (I) with an amino component. The 2-piperazine carboxylic acid amides of general formula (I) are lnter alia valuable intermediate products for preparing orally active HIV-1 protease inhibitors. |
| priorityDate | 1994-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.